Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership
CorMedix's DefenCath Ignites Stellar Q3 Performance, Elevating Full-Year Revenue Projections
Beyond Vaccines: Moderna Co-Founder Warns of Widespread Attacks on Science
A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access
Beyond COVID: mRNA Vaccines Unleash a New Weapon Against Cancer's Toughest Foes
A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025
A New Dawn for Breast Cancer Treatment: Roche's Gedatolisib and Giredestrant Combination Shows Promise
Taysha Gene Therapies Stock Takes a Dive: Unpacking the Impact of Their Latest Public Offering
Biotech's Vanguard: Novo Nordisk, Omeros, and GSK Charting New Territories in Medical Innovation
A Looming Crisis: Funding Cuts Threaten Revolutionary Cancer Immunotherapy Breakthroughs
Omeros Stock Skyrockets: Novo Nordisk Seals Massive $2.1 Billion Rare Disease Drug Deal
Bavarian Nordic's Future Intensifies: A Higher Bid Ignites Take-Private Battle
Merck's Breakthrough: Islatravir-Doravirine Matches Leading HIV Treatment in Pivotal Trials
North Carolina's Biotech Boom: Powering the Future of Medicine Through Advanced Manufacturing
Takeda and Nabla Bio Forge $1 Billion Alliance to Revolutionize Antibody Design with AI
FDA Pumps the Brakes: Denali Therapeutics' Hunter Syndrome Drug Faces Extended Review
BioCryst Pharmaceuticals Strikes Strategic $700 Million Deal, Propelling Astria's HAE Pipeline and Strengthening Its Own Focus
A New Dawn for ITP Patients: Telitacicept Shows Remarkable Promise in Autoimmune Disorder
Clinical Setback: Tvardi Therapeutics' Lung Disease Candidate Falls Short in Crucial Trial
Cullinan Therapeutics' Breakthrough Cancer Drug Shows Remarkable Efficacy Against Brain Metastases in Lung Cancer Patients
A New Dawn in Lung Cancer Treatment: Gilead and Arcus's Investigational Therapy Shows Promising Survival Advantage
The Production Predicament: How Manufacturing Woes Threaten Novo Nordisk's Blockbuster Drugs
Monopar Therapeutics: A Biotech Powerhouse Poised for Explosive Growth?
Beyond Cancer: Nkarta Pioneers a New Era for Autoimmune Diseases with Groundbreaking NK Cell Therapy
UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment
A Ray of Hope: Mainz Biomed's Pancreatic Cancer Test Delivers Unprecedented Early Detection Results
Unlocking Tomorrow's Cures: Bristol Myers Squibb's Daring Dive into Next-Gen Autoimmune Cell Therapies
US BioSecure Act Ignites Indian Pharma: A New Era for CDMOs
A New Dawn Against Breast Cancer: Telomir-1 Shows Remarkable Promise
Boston-Cambridge: The Unrivaled Epicenter of Global Biotech Innovation
Monopar's Breakthrough in Wilson Disease: A New Dawn with AstraZeneca's Shadow
Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future
Biomea Fusion Shares Plummet as Major Public Offering Rocks Investor Confidence Despite Positive Diabetes Data
Valneva's 2025 Outlook Takes a Hit as Key Vaccine Marketing Rights Shift in Brazil
Midday Market Movers: Biotech Rockets, Tech Soars, and a Coffee Giant Stumbles
A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients
The Great Pharmaceutical Reversal: Onshoring's Costly Gamble with Drug Affordability
Europe's Bold New Pharma Gambit: A High-Stakes Bet on Access Over Profit?
Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks
A Deluge of Innovation: Six IPOs Storm the Market, From Data Security to Biotech Breakthroughs
Phyllis Gardner, Stanford's Unwavering Voice of Truth Against Theranos, Passes Away
Crucial Medicare Drug Price Loophole Fix Stalled: A Setback for Patient Savings
Taysha Gene Therapies' TSHA-102 Receives FDA Breakthrough Status: A New Hope for Rett Syndrome